NCT07771790 Targeted Assessment of Cognition and Tactical-performance With Ingested Ketones
| NCT ID | NCT07771790 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Florida State University |
| Condition | Cognition |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-09-01 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-09-01 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to determine whether consuming a commercially available exogenous ketone supplement (KetoneIQ®) affects cognition, specifically marksmanship, under physical stress (i.e., exhaustive exercise). The main questions we seek to answer are: * Does the supplement save cognitive performance under stress compared to a placebo? * Does the supplement improve marksmanship under stress compared to a placebo?
Eligibility Criteria
Inclusion Criteria: * Active Member of an accredited Law Enforcement Special Weapons and Tactics Team (SWAT) * Health and capable of meeting testing requirements Exclusion Criteria: * Following a low-carbohydrate ketogenic diet * Self-reported Pregnancy * Allergy to testing materials * Currently using exogenous ketone supplements within one week of testing
Contact & Investigator
Michael J Ormsbee, PhD
PRINCIPAL INVESTIGATOR
Florida State University
Frequently Asked Questions
Who can join the NCT07771790 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cognition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07771790 currently recruiting?
Yes, NCT07771790 is actively recruiting participants. Contact the research team at mormsbee@fsu.edu for enrollment information.
Where is the NCT07771790 trial being conducted?
This trial is being conducted at Tallahassee, United States.
Who is sponsoring the NCT07771790 clinical trial?
NCT07771790 is sponsored by Florida State University. The principal investigator is Michael J Ormsbee, PhD at Florida State University. The trial plans to enroll 20 participants.